Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 223 shares at $844.00 ($188K) on 2023-08-23, disclosed to the SEC on 2023-08-25.
Open-market sale of $188k REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |
| REGN | SELL | 2022-12-02 | $462K | — | Filing → |